Manufacturing

Oct 11, 2018
By Pharmaceutical Technology Editors
The new facility will include comprehensive mammalian process development and manufacturing capabilities.
Oct 10, 2018
By Pharmaceutical Technology Editors
The companies signed a three-year clinical manufacturing agreement to manufacture GlaxoSmithKline’s specific peptide enhanced affinity receptor T-cell receptor therapy for United States, Canadian, and European clinical trials.
Oct 10, 2018
By Pharmaceutical Technology Editors
The companies will develop and commercialize ARO-HBV, a Phase I/II subcutaneous, ribonucleic acid interference therapy candidate being investigated for the treatment of chronic hepatitis B viral infection.
Oct 09, 2018
By Pharmaceutical Technology Editors
The UCL-Pall Biotech Centre of Excellence will address industry challenges and provide workforce training.
Oct 09, 2018
By Pharmaceutical Technology Editors
At CPhI Worldwide 2018, Tom Wilson, vice president of Contract Manufacturing Operations for Pfizer Global Supply and Pfizer CentreOne Contract Manufacturing, will discuss best practices for meeting manufacturing challenges of compliance as requirements shift.
Oct 05, 2018
By Pharmaceutical Technology Editors
Luxembourg-based pharmaceutical group, C2 Pharma (formerly known as Centroflora CMS) successfully validated the manufacturing process for two APIs—digoxin and digoxin micron.
Oct 05, 2018
By Pharmaceutical Technology Editors
The new bioLIVE event, launching this year with CPhI Worldwide 2018, will explore innovation in bioprocessing and manufacturing with a focus on the roles of innovative methods and technology for biopharma continuous manufacturing.
Oct 05, 2018
By Pharmaceutical Technology Editors
Advances in biologic drug development require increased methodological and technological innovation from the biopharma industry. Learn more at the new bioLIVE launching this year adjacent to CPhI Worldwide 2018.
Oct 03, 2018
By Pharmaceutical Technology Editors
The companies will work together to discover, develop, and commercialize immunotherapies for patients with solid-tumor cancers in a collaboration worth $695 million per program.
Oct 02, 2018
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Ross, Charles & Son added a custom 150-gallon Triple Shaft Mixer, the Ross VersaMix Model VMC-150, with elaborate automation and safety functions.
native1_300x100
lorem ipsum